Ictero Medical, Inc. — SEC Form D Filing

Ictero Medical, Inc. filed an SEC Form D on November 5, 2026, reporting $344K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
November 5, 2026
Amount reported
$344K
Round stage
Seed
Industry
Medical Devices
Website
https://icteromedical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients suffer from gallstone disease and face the inherent risks associated with traditional surgical treatment options.

Solution

Ictero Medical is developing The CholeSafe System, a minimally invasive gallbladder ablation solution designed to treat gallstone disease with the benefits of surgery but without surgical risk.

Why now

Advances in catheter-based ablation technology and imaging guidance now enable targeted organ ablation, meeting growing hospital demand for lower-risk outpatient alternatives to laparoscopic surgery.

Verdict

This cleared because targeting high-risk, non-surgical gallstone patients offered an immediate, desperate wedge against dreaded external drainage tubes, not because hospitals were actively clamoring to replace routine laparoscopic cholecystectomies. Investors implicitly bet that interventional radiologists could carve out procedural territory without triggering fatal specialty turf wars with general surgeons. However, upside remains strictly capped by the brutal clinical and regulatory runway required for safe organ necrosis, rendering a micro-seed round dangerously thin for real clinical de-risking.

Source: SEC EDGAR Form D filing